CARDOZA GEORGE 4

What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), reported two open-market sales to satisfy tax withholding on recently vested restricted stock units. On 2026-04-06 he sold 2,520 shares at a weighted-average price of $4.85 for $12,211, and on 2026-04-07 he sold 2,413 shares at a weighted-average price of $4.88 for $11,768 — a total of 4,933 shares and $23,979 disposed. These were sales (not purchases) and are described as routine tax-withholding transactions rather than discretionary trades.

Key Details

• Transaction dates: 2026-04-06 (2,520 shares @ $4.85 WA) and 2026-04-07 (2,413 shares @ $4.88 WA). Total proceeds: $23,979.
• Price ranges: 4/6 sales executed across $4.66–$4.95; 4/7 sales executed across $4.70–$5.01 (weighted averages reported). Reporting person can provide per-price breakdown on request.
• Reason: Sales effected to satisfy tax withholding obligations for RSU vestings on April 2 and April 3, 2026 (Footnote F1).
• Plan: Sales conducted pursuant to a pre-established Rule 10b5-1 trading plan and were not discretionary (Footnote F1).
• Filing timeliness: Report filed 2026-04-08 for transactions on 2026-04-06 and 04-07 — appears timely (Form 4 due within two business days).
• Shares owned after the transactions: not specified in the provided excerpt; consult the full Form 4 for post-transaction holdings.

Context These sales were tax-withholding transactions tied to RSU vesting and executed under a 10b5-1 plan, which is common and generally not taken as a signal of the insider’s view on the stock. For retail investors, purchases or large, discretionary insider buys tend to carry more interpretive weight than routine withholding sales of this modest size (~$24k).